These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21664130)

  • 21. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
    Rostom SA
    Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of 4-arylphthalazones bearing benzenesulfonamide as anti-inflammatory and anti-cancer agents.
    Yaseen S; Ovais S; Bashir R; Rathore P; Samim M; Singh S; Nair V; Javed K
    Arch Pharm (Weinheim); 2013 Jun; 346(6):491-8. PubMed ID: 23670888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
    Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
    Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
    Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
    Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents.
    Khode S; Maddi V; Aragade P; Palkar M; Ronad PK; Mamledesai S; Thippeswamy AH; Satyanarayana D
    Eur J Med Chem; 2009 Apr; 44(4):1682-8. PubMed ID: 18986738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of some novel sulfamoylphenyl-pyridazinone as anti-inflammatory agents (Part-II * ).
    Bashir R; Yaseen S; Ovais S; Ahmad S; Hamid H; Alam MS; Samim M; Javed K
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):92-6. PubMed ID: 21612377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological evaluation and molecular modeling study of 5-trifluoromethyl-Δ²-pyrazoline and isomeric 5/3-trifluoromethylpyrazole derivatives as anti-inflammatory agents.
    Aggarwal R; Bansal A; Rozas I; Kelly B; Kaushik P; Kaushik D
    Eur J Med Chem; 2013; 70():350-7. PubMed ID: 24177361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, analgesic and anti-inflammatory activities of some 1-acyl/aracyl-5-aminopyrazole derivatives.
    Gadad AK; Kittur BS; Kapsi SG; Mahajanshetti CS; Rajur SB
    Arzneimittelforschung; 1996 Nov; 46(11):1082-5. PubMed ID: 8955869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
    Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
    Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Biological Evaluation of New Phthalazinone Derivatives as Anti-Inflammatory and Anti-Proliferative Agents.
    Hameed AD; Ovais S; Yaseen R; Rathore P; Samim M; Singh S; Sharma K; Akhtar M; Javed K
    Arch Pharm (Weinheim); 2016 Feb; 349(2):150-9. PubMed ID: 26725221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of some novel pyrazole derivatives as potential antiinflammatory agents with minimum ulcerogenic activity.
    el-Hawash SA; el-Mallah AI
    Pharmazie; 1998 Jun; 53(6):368-73. PubMed ID: 9675765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.